Credits Available: 4.75 hours of AMA PRA Category 1 Credit™; ABIM MOC

Description: Despite significant advancements in treatment, multiple myeloma remains an incurable disease, and nearly all patients experience relapse, often requiring increasingly complex therapeutic strategies.

With the rapid expansion of treatment options, particularly novel targeted therapies such as GPRC5D-directed approaches, the landscape of relapsed/refractory multiple myeloma (RRMM) management is evolving at an unprecedented pace. While these agents offer deep and durable remissions, their integration into clinical practice presents challenges in sequencing, toxicity management, and multidisciplinary coordination.

This educational initiative is designed to empower clinicians with the latest insights on GPRC5D-targeted therapies, facilitate the exchange of real-world clinical experience, and provide actionable strategies for optimizing patient outcomes. Through interactive discussions and expert-led guidance, participants will gain practical knowledge to navigate the complexities of RRMM treatment while fostering collaborative networks to enhance long-term patient care.

Join us to stay at the forefront of innovation in multiple myeloma management and elevate your clinical practice.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Nurse, Physician Associate/Assistant
Target Specialties: Hematology, Hematology/Oncology, Oncology
Group Leader

Matthew Lunning

University of Nebraska Medical Center
Associate Professor

I work primarily with lymphoma patients in the newly diagnosed and rel/ref settings. I have been active in the development and participation in CAR-T cell trials in multiple NHL diagnoses.

 

Group Co-Leader

Katherine Byar

Nebraska Medicine
Hematological Malignancy Nurse Practitioner

Katherine Byar, MSN, APRN-BC, BMTCN® is an malignant hematology/oncology nurse practitioner at the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska.

Ms. Byar received her Master of Science in Nursing at the University of Nebraska Medical Center. She is certified as an Adult Nurse Practitioner and a Bone Marrow Transplant Certified Nurse.

With more than 30 years of experience and holding a variety of diverse roles in oncology, Katherine is recognized as a national nurse practitioner leader. She is currently working as an outpatient Advance Practice Provider responsible for the care of patients with hematological malignancies. Her clinical expertise includes hematologic malignancies, oncologic emergencies, CAR T-cell therapy, hematopoietic cell transplantation, survivorship, and supportive care. She is a prominent educator who has delivered hundreds of educational presentations to national and international audiences and authored numerous peer-reviewed publications, web courses, and book chapters. Ms. Byar co-edited the “ONS Cancer Basics third edition”. She also is an active member of the Oncology Nursing Society (ONS), and the Advanced Practitioner Society of Hematology and Oncology (APSHO).